Primary study · included by 1 review

Oral management with polaprezinc solution reduces adverse events in haematopoietic stem cell transplantation patients.

Tsubura-Okubo 2021 · Tsubura-Okubo M, Komiyama Y, Kamimura R, et al. · International journal of oral and maxillofacial surgery · 2021

Included by

Non-Cochrane · intervention · 2026 · cited as Tsubura-Okubo 2021 · Table 1; Figure 4

Outcome this study informs	Pooled effect	Evidence	Certainty
Severe oral mucositis (grade >= 3), incidence Zinc L-carnosine (polaprezinc) in any formulation (mouthwash, lozenge, mucoadhesive suspension) vs Standard oral care, no prophylaxis, azulene gargle, sodium bicarbonate mouthwash or delayed ZnC	OR 0.44 [0.18, 1.06]	7 studies · 532 participants	Low
Severe oral mucositis (grade >= 3), incidence Zinc L-carnosine (polaprezinc) in any formulation (mouthwash, lozenge, mucoadhesive suspension) vs Standard oral care, no prophylaxis, azulene gargle, sodium bicarbonate mouthwash or delayed ZnC	OR 0.48 [0.32, 0.72]	7 studies · 532 participants	Low

1 including review in total.